Growth Metrics

Zevra Therapeutics (ZVRA) Gains from Sales and Divestitures (2024)

Zevra Therapeutics' Gains from Sales and Divestitures history spans 1 years, with the latest figure at $765945.0 for Q4 2024.

  • For Q4 2024, Gains from Sales and Divestitures changed N/A year-over-year to $765945.0; the TTM value through Dec 2024 reached $765945.0, changed N/A, while the annual FY2024 figure was $765945.0, N/A changed from the prior year.
  • Gains from Sales and Divestitures reached $765945.0 in Q4 2024 per ZVRA's latest filing.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $765945.0 in Q4 2024 to a low of $765945.0 in Q4 2024.